Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Retreatment with talquetamab and pomalidomide in triple-class-BCMA-GPRC5D refractory myeloma.
Journal: British journal of haematology
Published: January 23, 2026
Is Pseudo-progression post-CAR T therapy real?
Journal: Clinical hematology international
Published: January 11, 2026
Outpatient Administration of Bispecific Antibody Therapy for Hematologic Malignancies: A Practical Guide.
Journal: JCO oncology practice
Published: December 04, 2025
Leukemia cutis and all-trans retinoic acid-induced myocarditis in acute promyelocytic leukemia.
Journal: Clinical hematology international
Published: November 11, 2025
"Thromboembolism in transplant-ineligible multiple myeloma patients on triplet/quadruplet therapy: a post hoc analysis of BENEFIT": comment from Galarza Fortuna et al.
Journal: Journal of thrombosis and haemostasis : JTH
Published: July 25, 2025
Rapid identification of inflammatory arthritis and associated adverse events following immune checkpoint therapy: a machine learning approach.
Journal: Frontiers in immunology
Published: November 02, 2023
Lung Cancer Survival in Patients With Autoimmune Disease.
Journal: JAMA network open
Published: December 14, 2020
Venetoclax in Combination With Bortezomib, Dexamethasone, and Daratumumab for Multiple Myeloma.
Journal: Clinical lymphoma, myeloma & leukemia
Published: February 27, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026